Home » Products » Dry Injections » Ceftazidime 250 mg & Tazobactum 31.25 mg Dry Injection (281.25 mg)

Ceftazidime 250 mg & Tazobactum 31.25 mg Dry Injection (281.25 mg)

Ceftazidime 250 mg & Tazobactum 31.25 mg Dry Injection (281.25 mg)
Ceftazidime 250 mg & Tazobactum 31.25 mg Dry Injection (281.25 mg)
Send Inquiry
Product Code : 125
Brand Name : Ceftazidime 250 mg
Product Specifications
  • Formulations Type
  • Injectables
  • Formulations Form
  • Powder
Product Description

Ceftazidime 250 mg & Tazobactum 31.25 mg Dry Injection (281.25 mg)


Ceftazidime

Ceftazidime 250 mg Dry Injection

1X24

With SWFI

Ceftazidime 500 mg Dry Injection

1X24

With SWFI

Ceftazidime 1000 mg Dry Injection

1X15

With SWFI

Ceftazidime 250 mg & Tazobactum 31.25 mg Dry Injection (281.25 mg)

1X24

With SWFI

Ceftazidime 1000 mg & Tazobactum 125 mg Dry Injection (1125 mg)

1X15

With SWFIa


Trade Information
  • Packaging Details
  • 1X24 With SWFI
  • Main Export Market(s)
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
  • Main Domestic Market
  • All India

G. NINE BIOCEUTICALS PVT. LTD.
X



  • ISO 9001-2008 & GMP certified company
  • 208-F, Sec-3, HSIIDC Industrial Estate, Karnal - 132001, Haryana, India
  • Key Person
  • Mr Shubham SONU (General Manager-Sales & Mktg.)
  • Mr. Rajesh Arora (Director)
  • Mr. Narender Arora (Director)
  • Send Inquiry

Product Showcase